The iRR6 model refines risk stratification for intermediate-1 myelofibrosis patients, incorporating ruxolitinib dosing, spleen reduction, and transfusion needs. Validation in an external cohort ...
BEIJING (Reuters) -Chinese AI developer DeepSeek has released its "experimental" latest model, which it said was more efficient to train and better at processing long sequences of text than previous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback